It has also been demonstrated that the expression levels of CEACAM6 are higher than those of CEA in malignant tumors including breast cancer, lung cancer, prostate cancer, colon cancer, pancreatic cancer, and ovarian cancer. This evidence concerns the gene CEACAM5 and cancer.